Who we are

MS Pen Technologies is empowering researchers, surgeons and clinicians with molecular data at the point of need to drive better outcomes for patients.

We envision a future where molecular
data can be used at the point of need to
better serve patients

In the news

The world is taking notice

Medical 'Pen' can detect cancer in 10 seconds

2023 Finalists MS Pen Technologies, Inc. MasSpec Pen

This pen can diagnose cancer in 10 seconds

MacArthur ‘Genius Grant’ Winner Includes Inventor of MasSpec Pen

This pen diagnoses cancer mid-surgery in seconds

‘Cancer Pen’ Lets Docs Spot Tumor Cells in Seconds

Cancer pen could detect tumors during surgery in seconds

‘Pen’ identifies cancer in 10 seconds

Handheld MasSpec Pen for molecular cancer detection during surgeries

Breakthrough Medical Technologies So Crazy They Sound like Science fiction

Team

Justin Wiseman, PhD

CEO & Board Dir.

Entrepreneur, Inventor, Former President & CEO of Prosolia, Inc.
Led acquisition of Prosolia by Waters, Corp.
Distinguished Science Alumni Entrepreneur, Purdue University

Livia Eberlin, PhD

Co-founder, CSO, Board Dir.

Associate Professor, Michael E. DeBakey Department of Surgery
Director, INSTINCT Surgical Technology & Innovation Center
MacArthur Fellow, “Genius Grant” recipient
Forbes 30 under 30 in medicine

James Suliburk, MD

Co-founder, CMO, Board Dir.

Chief of Endocrine Surgery and Professor of Surgery at Baylor College of Medicine
TS Reeve International Fellow in Endocrine Surgery